Status:
ACTIVE_NOT_RECRUITING
Brain Health & the Microbiome
Lead Sponsor:
George Washington University
Conditions:
Mild Cognitive Impairment
Mild Dementia
Eligibility:
All Genders
50-90 years
Brief Summary
The GW SMHS supports research in complementary and integrative approaches to treatment of sickness and disease and for health promotion. Sometimes, research may involve asking questions of patients, s...
Detailed Description
AD is, in a word, devastating. The massive psychological and physical trauma experienced by people with dementia and their loved ones is catastrophic and incapable of overestimation. It is incumbent u...
Eligibility Criteria
Inclusion
- Age 50-90
- Early Alzheimer's Disease (eAD)
- Mild Cognitive Impairment (MCI)
- Healthy Control (no eAD or MCI)
Exclusion
- Criteria or pathology that may affect the outcomes of the study or the risk/benefit ratio as determined by the study team
Key Trial Info
Start Date :
August 25 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 24 2025
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06039267
Start Date
August 25 2023
End Date
August 24 2025
Last Update
December 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
George Washington University School of Medicine & Health Sciences
Washington D.C., District of Columbia, United States, 20037